Announcements Trials
Browse Landscape

Status

Completed 25Unknown 5Terminated 1Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Specimen Handling 5Surveys and Questionnaires 4Observation 4Blood Specimen Collection 4Drug Therapy 3Chemoradiotherapy 3Surgical Procedures, Operative 2Electrocardiography 2Echocardiography 2Capecitabine 2Biopsy 2trifluridine tipiracil drug combination 1tegafur-gimeracil-oteracil 1somapacitan 1olverembatinib 1lorlatinib 1lenvatinib 1gallium 68 PSMA-11 1brexucabtagene autoleucel 1axicabtagene ciloleucel 1Zoledronic Acid 1Tumor Burden 1Telemedicine 1Tegafur 1Stents 1Spermine Synthase 1S 1 (combination) 1Robotic Surgical Procedures 1Rituximab 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Observational × Rituximab × Clear all
NCT05690191 2023-01-19

Chidamide in Patients With Recurrent and Refractory Diffuse Large b

Second Affiliated Hospital of Soochow University

Enrolling by invitation
169 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡